Adaptimmune Therapeutics 2023 Annual Report 10-K

Adaptimmune Therapeutics PLC's Form 10-K annual report for the fiscal year ended December 31, 2023. The report covers the company's business operations, financial condition, risk factors, and corporate governance as a non-accelerated filer and emerging growth company in the biotechnology sector.